Is a complete XENE research report available?

No complete published report is available for Xenon Pharmaceuticals Inc. (XENE) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

Xenon Pharmaceuticals Inc. (XENE)

NASDAQ: XENE · USD

$65.4

+0.00 (0.0%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-27 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first XENE analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	6.3B
Net income (ttm)	-383.2M
EPS (ttm)	-$4.71
Shares out	96.7M
Volume	528,927
Beta	0.61
Price target	$80.9	+23.7%

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -383.2M
EPS (ttm): -$4.71
Market cap: 6.3B

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
ALNY	Alnylam Pharmaceuticals, Inc.	38.3B	72.6x	8.9x	78.4%	+49.7%	-11.8%	Strong Buy
ARGX	argenx SE	55.2B	32.2x	10.4x	50.6%	+58.8%	+48.3%	Strong Buy
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Hold

All XENE indicators

Market & fundamental data

Available fields

186

Groups with data

Currency

USD

Showing 186 of 186 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001582313
Company name	Xenon Pharmaceuticals Inc.
Country	Canada
Country code	US
Cusip	98420N105
Employees	370
Employees Change	43%
Employees Change Percent	13.15
Enterprise value	$5B
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	2014-11-05
Isin	CA98420N1050
Last refreshed	2026-07-27
Market cap	$6.3B
Market cap category	Mid-Cap
Price	$65.42
Price currency	USD
Sector	Healthcare
Sector PE	44.88
Sector PE Fwd	23.79
Sic	2834
Symbol	XENE
Website	https://www.xenon-pharma.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-6.06%
EV Sales Forward	2,892.28x
FCF yield	-4.86%
P/B ratio	4.72x
PS Forward	3,664.14x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-328.2M
Net Income	$-383.2M
Net Income Growth Years	0%
Profit Per Employee	$-1M
ROA	-24.22
Roa5y	-18.62
ROCE	-30.64
ROE	-37.53
Roe5y	-28.66
ROIC	-25.07

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	24.44%
Cagr1y	109.85%
Cagr3y	20.91%
Cagr5y	29.02%
EPS Growth Years	0
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$1.4B
Cash	$1.1B
Current Assets	$1.1B
Current Liabilities	$39.8M
Debt	$7.5M
Debt Equity	$0.01
Equity	$1.3B
Liabilities	$49M
Long Term Assets	$280.2M
Long Term Liabilities	$9.2M
Net Cash	$1.3B
Net Cash By Market Cap	$21.07
Net Cash Growth	95.2%
Net Debt Equity	$-1
Tangible Book Value	$1.3B
Tangible Book Value Per Share	$13.85
WACC	7.61

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	27.79
Net Working Capital	$-26.4M
Quick ratio	27.53
Working Capital	$1.1B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.16%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	790.07%
1Y total return	109.75%
200-day SMA	49.53
3Y total return	76.76%
50-day SMA	58.26
50-day SMA vs 200-day SMA	50over200
5Y total return	257.49%
All Time High	72.66
All Time High Change	-9.96%
All Time High Date	2026-07-09
All Time Low	2.1
All Time Low Change	3,015.24%
All Time Low Date	2017-11-16
ATR	2.23
Beta	0.61
Beta1y	0.41
Beta2y	0.77
Ch YTD	45.96
High	65.99
High52	72.66
High52 Date	2026-07-09
High52ch	-9.96%
Low	64.27
Low52	30
Low52 Date	2025-08-01
Low52ch	118.07%
Ma50ch	12.28%
Premarket Change Percent	0.73
Premarket Price	$65.9
Premarket Volume	10,381
Price vs 200-day SMA	32.08%
RSI	58.15
RSI Monthly	70.95
RSI Weekly	67.96
Sharpe ratio	1.42x
Sortino ratio	4.27
Tr YTD	45.96
Tr1m	19.8%
Tr1w	-4.16%
Tr3m	18.07%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	20
Analyst Count Top	17
Analyst Price Target Top	$77.92
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-1.16
Earnings Revenue Estimate	937,500x
Operating Income	$-412.7M
Price target	$80.93
Price Target Change	$23.14
Price Target Change Top	$19.11

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	90,757,893%
Float Percent	93.89%
Shares Insiders	0.13%
Shares Institutions	97.7%
Shares Out	96,665,550
Shares Qo Q	9.01%
Shares Yo Y	4.16%
Short Float	6.89%
Short Ratio	3.56
Short Shares	6.47

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-365.7M
Average Volume	1,779,212.5x
Bv Per Share	13.85
CAPEX	$-889,000
Ch10y	790.1
Ch1m	19.8
Ch1w	-4.16
Ch1y	109.7
Ch3m	18.07
Ch3y	76.76
Ch5y	257.5
Ch6m	56.66
Change	0%
Change From Open	-0.86
Close	65.42
Days Gap	0.87
Depreciation Amortization	2,471,000
Dollar Volume	34,602,404.3
Earnings Date	2026-08-07
Earnings Time	amc
EBIT	$-412.7M
EBITDA	$-410.2M
EPS	$-4.71
F Score	2
FCF	$-307.3M
FCF EV Yield	-6.16x
FCF Per Share	$-3.18
Financing CF	958,975,000
Fiscal Year End	December
Founded	1,996
Income Tax	$-2M
Investing CF	-223,794,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-07
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-26
Ma150	52.13
Ma150ch	25.49%
Ma20	65.15
Ma20ch	0.41%
Net CF	429,210,000
Next Earnings Date	2026-08-10
Open	65.99
Optionable	Yes
Position In Range	66.86
Ppne	14,582,000
Pre Close	65.42
Price Date	2026-07-24
Ptbv Ratio	4.73
Relative Volume	0.3x
Share Based Comp	58,427,000
Tr6m	56.66%
Volume	528,927
Z Score	36.19

Xenon Pharmaceuticals Inc. (XENE)

Coverage state: Market snapshot only — no published research

Generate the first XENE analysis

Price

Financial snapshot

Fair-value bridge

Analyst consensus

Latest news · XENE

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XENE indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on XENE

Frequently asked questions